NCT00051038
Completed
Phase 2
A Phase II Study of the Safety and Efficacy of Adding Entecavir to Current Lamivudine Therapy in HIV and HBV Co-Infected Patients Who Have Hepatitis B Viremia While Being Treated With Lamivudine
ConditionsHepatitis B
DrugsEntecavir
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Hepatitis B
- Sponsor
- Bristol-Myers Squibb
- Locations
- 1
- Status
- Completed
- Last Updated
- 15 years ago
Overview
Brief Summary
The purpose of this clinical research study is to assess the safety and effectiveness of entecavir, when being added to lamivudine, in the treatment of adults with chronic hepatitis B infection who are co-infected with HIV.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 2
Safety and Antiviral Activity of Entecavir in Participants With Chronic Hepatitis B Following Monotherapy in Other Entecavir TrialsHepatitis B VirusHBVNCT01438424Bristol-Myers Squibb1,053
Completed
Phase 3
A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Positive for Hepatitis B E AntigenChronic Hepatitis BNCT00035633Bristol-Myers Squibb
Active, not recruiting
Phase 2
A Safety and Efficacy Study of Treatment Combinations With and Without Chemotherapy in Adult Participants With Advanced Upper Gastrointestinal Tract MalignanciesGastrointestinal Tract MalignanciesNCT05329766Arcus Biosciences, Inc.332
Active, not recruiting
Not Applicable
Clinical Study of the Treovance Stent-Graft for Patients With Abdominal Aortic AneurysmsAbdominal Aortic Aneurysm (AAA)NCT02009644Bolton Medical158
Terminated
Phase 2
Therapeutic Cancer Vaccine (AST-301, pNGVL3-hICD) in Patients With Breast CancerBreast CancerNCT05163223Aston Sci. Inc.10